BioAsia 2026: Telangana Leads TechBio Revolution with AI and Healthcare Innovations
February 17, 2026
Plans to shift from supply-led manufacturing to solution-driven leadership by building talent in mRNA, gene editing, and AI-driven drug discovery, while boosting Hyderabad’s role in medical tourism.
The event aims to unite researchers, entrepreneurs, investors, and policymakers to accelerate the TechBio revolution and tackle major global health challenges.
The opening ceremony was led by the Telangana Chief Minister, with Prof. Bruce L. Levine receiving the Genome Valley Excellence Award for cancer gene therapy.
Inauguration and awards highlight Telangana’s leadership in life sciences, honoring Levine for cancer gene therapy work during the opening ceremony.
BioAsia 2026, Asia’s leading life sciences and health tech forum, opened in Hyderabad as its 23rd edition, with a focus on AI, automation, and data science to drive the next wave of healthcare innovation.
More than 175 exhibitors across pharmaceuticals, biotechnology, medtech, digital health, and advanced manufacturing are taking part, underscoring a broad, cross-sector TechBio showcase.
Telangana highlights its strong policies, skilled human resources, and premier educational institutions as core strengths fueling growth in life sciences.
Telangana unveiled initiatives like the Young India Skills University and Telangana School of Life Sciences to build talent in mRNA technology, gene therapy, and AI.
Recent initiatives cited include Telangana Next-Gen Life Sciences Policy, Genome Valley expansion, launch of 1Bio, and multiple global capability centres in Hyderabad.
Ongoing collaborations among research institutions, corporates, startups, MSMEs, and government were emphasized to create a trusted, future-ready life sciences ecosystem in Telangana.
Telangana Rising 2047 envisions making Telangana a USD 1 trillion economy by 2034 and USD 3 trillion by 2047 through collaboration across research labs, industry, startups, MSMEs, and government.
Telangana Life Sciences Policy 2026-30 promotes cross-border collaboration, international capital, and translation of breakthroughs into healthcare solutions to position Telangana as a global life sciences hub.
Summary based on 12 sources
Get a daily email with more World News stories
Sources

Economic Times • Feb 17, 2026
CM Revanth Reddy pitches Telangana as biopharma investment destination
The Hindu • Feb 17, 2026
CM Revanth opens BioAsia, reaffirms Telangana’s support for Life Sciences industry’s scale-up
The Siasat Daily • Feb 17, 2026
CM Revanth Reddy pitches Telangana as biopharma investment destination
footer-brand-icon • Feb 15, 2026
BioAsia 2026 to kick off in Hyderabad with record 4,000 delegates; CM Revanth Reddy to inaugurate on Feb 17